Adrenal gland disease in ferrets is managed with either surgical adrenalectomy or medical suppression of sex steroid production, with the choice driven by surgical candidacy, concurrent disease, and owner preference.
Surgical adrenalectomy is the treatment of choice for ferrets with adrenocortical tumors. Adrenalectomy of the diseased gland alleviates clinical signs in most ferrets and carries a good long-term prognosis, though recurrence of disease after surgery is possible.Journal of the… Surgery combined with hormonal suppression is an option for ferrets with certain adrenal tumors.Journal of the…
Medical management is preferred when ferrets are geriatric, have concurrent disease, or surgery is declined for economic reasons. Available medical options manage clinical signs but do not cure the underlying adrenal disease — the gland may continue to enlarge despite treatment.Veterinary Clin… Gonadotropin-releasing hormone (GnRH) agonists do not reduce tumor size or halt tumor growth, but do suppress clinical signs of adrenal disease.Journal of the… Medical management of adrenal tumors has a greater disease-free period compared to adrenalectomy.Veterinary Clin…
GnRH agonist therapy is the primary medical modality. Deslorelin acetate, a depot GnRH agonist, is administered as a subcutaneous implant; one ferret in the literature was managed with serial deslorelin implants, with the last placed 7 months prior to disease progression.Journal of the… Leuprolide acetate (depot suspension, 30-day formulation) is administered at 0.35 mg/kg IM every 30 days; fur regrowth was confirmed after 2 months of treatment in a ferret with hyperestrogenism.Journal of the…
Secondary complications of adrenal disease require targeted management. Prostatic enlargement causing urinary obstruction and nonregenerative anemia from hyperestrogenism are both addressed within the medical management framework.Veterinary Clin… Bone marrow suppression may occur in severe cases of hyperandrogenism.Journal of the…
Clinical signs that should prompt evaluation and treatment include bilateral symmetrical truncal alopecia, vulvar enlargement in spayed females, prostatic hyperplasia with risk of urinary obstruction in males, mammary gland hyperplasia, and behavioral changes such as mounting, urine marking, and aggression in sterilized animals.Journal of the…
| Treatment | Protocol | Efficacy | Key Caveat |
|---|---|---|---|
| Adrenalectomy | Surgical excision of affected gland | Alleviates signs in most ferrets; good long-term prognosis | Recurrence possible; requires surgical candidacyJournal of the… |
| Deslorelin acetate | Subcutaneous implant (depot GnRH agonist) | Suppresses clinical signs | Does not reduce tumor size; disease may progressJournal of the…+1 |
| Leuprolide acetate | 0.35 mg/kg IM q30 days (30-day depot formulation) | Fur regrowth confirmed at 2 months | Does not reduce tumor sizeJournal of the…+1 |
| Medical alone | GnRH agonist ± complication management | Manages symptoms; greater disease-free period vs. surgery per one source | Gland continues to enlarge; not curativeVeterinary Clin…+1 |
Would you like to discuss how to monitor treatment response and determine when a deslorelin implant needs replacement?